Oncology collaboration: Proteros & MSD to find epigenetic target
Proteros has entered into a second research agreement with Merck…
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Proteros has entered into a second research agreement with Merck aimed at developing small molecule compounds against an additional epigenetic target...